AEF0217 in Participants With Down Syndrome

Abroad (travel likely)RecruitingPHASE2

Conditions

Down Syndrome (Trisomy 21)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • CHU de Bordeaux, Bordeaux, France

    Contact: Study coordinator (Emilie ROQUAND WAGNER, MD) · emilie.roquand@chu-bordeaux.fr · +33557820353
    Contact: Principal Investigator (Emilie ROQUAND WAGNER, MD)
  • Genetics department, Hospices Civils de Lyon, Lyon, France

    Contact: Study coordinator (Damien SANLAVILLE, MD) · damien.sanlaville@chu-lyon.fr · +33472129639
    Contact: Principal Investigator (Damien SANLAVILLE, MD)
  • Service Génétique Médicale, CHU de Montpellier, Montpellier, France

    Contact: Study coordinator (Marjolaine WILLEMS, MD) · m-willems@chu-montpellier.fr · +33467336564
    Contact: Principal Investigator (Marjolaine WILLEMS, MD)
  • Genetics department, Institut Jérôme Lejeune, Paris, France

    Contact: Study coordinator (Marie-Anne CAILLAUD) · marie-anne.caillaud@institutlejeune.org
    Study coordinator · +33156586300
    Contact: Principal Investigator (Pierre Yves MAILLARD, MD)
  • Service de Génétique, Chromosomique et Moléculaire, Chu de Saint Etienne, Saint-Etienne, France

    Contact: Study coordinator (Renaud TOURAINE, MD) · renaud.touraine@chu-st-etienne.fr · +33477828116
    Contact: Principal Investigator (Renaud TOURAINE, MD)
  • IRCCS Istituto Delle Scienze Neurologiche, Azienda Unita Sanitaria Locale Di Bologna, Bologna, Italy

    Contact: Study coordinator (Luisa SAMBATI, MD) · luisa.sambati@ausl.bologna.it · +393207959682
    Contact: Principal Investigator (Luisa SAMBATI, MD)
    Gian Luca PIRAZZOLI, MD (Sub-investigator)
  • Centro di Medicina dell'Invecchiamento, Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy

    Contact: Study coordinator (Angelo CARFI, MD) · angelo.carfi@policlinicogemelli.it · +393394611458
    Contact: Principal Investigator (Angelo CARFI, MD)
  • UOR of Neurofarmacology and Translational Neurosciences, Associazione Oasi Maria S.S.Onlus, Troina, Italy

    Contact: Study coordinator (Filipo CARACI, MD) · filippo.caraci@unict.it · +393287157376
    Contact: Principal Investigator (Filipo CARACI, MD)
  • Integrative Pharmacology and Systems Neurosciences, Hospital del Mar Research Institute, Barcelona, Spain

    Contact: Study coordinator (Rafael DE LA TORRE FORNELL, PharmD, PhD) · rtorre2@researchmar.net · +34933160484
    Contact: Principal Investigator (Rafael DE LA TORRE FORNELL, PhD, PharmD)
    Ana ALDEA PERONA, MD (Sub-investigator)
  • Servicio de Medicina Interna, Hospital Universitario De La Princesa, Madrid, Spain

    Contact: Study coordinator (Diego REAL DE ASUA, MD) · diego.realdeasua@salud.madrid.org · +34915202200
    Contact: Principal Investigator (Diego REAL DE ASUA, MD)
Study leads
  • Pier Vincenzo PIAZZA, MD, PhD

    Study Chair

    Aelis Farma

  • Rafael DE LA TORRE FORNELL, PharmD, PhD

    Principal Investigator

    Hospital del Mar Research Institute